Laurent Peyrin-Biroulet to Proof of Concept Study
This is a "connection" page, showing publications Laurent Peyrin-Biroulet has written about Proof of Concept Study.
Connection Strength
0.037
-
Increasing Infliximab Dose Based on Symptoms, Biomarkers, and Serum Drug Concentrations Does Not Increase Clinical, Endoscopic, and Corticosteroid-Free Remission in Patients With Active Luminal Crohn's Disease. Gastroenterology. 2018 04; 154(5):1343-1351.e1.
Score: 0.037